Hepatitis B virus (HBV) core antigen-specific regulatory T cells confer sustained remission to anti-HBV therapy in chronic hepatitis B with acute exacerbation. [electronic resource]
Producer: 20111227Description: 687-98 p. digitalISSN:- 1879-1166
- Antiviral Agents -- therapeutic use
- Cell Proliferation
- Cytotoxicity, Immunologic
- Epitope Mapping
- Epitopes -- metabolism
- Forkhead Transcription Factors -- biosynthesis
- Hepatitis B Core Antigens -- immunology
- Hepatitis B virus -- immunology
- Hepatitis B, Chronic -- drug therapy
- Histocompatibility Antigens Class II -- metabolism
- Humans
- Immunosuppression Therapy
- Liver Failure
- Protein Binding
- Remission Induction
- T-Cell Antigen Receptor Specificity
- T-Lymphocyte Subsets -- immunology
- T-Lymphocytes, Regulatory -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.